SCHEMBL3662287

SCHEMBL3662287

CCCCS(=O)(=O)c1ccc(C)cc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ POLB P06746 1/20 0.40
▸ MCHR1 Q99705 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ GAA P10253 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HPGD P15428 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ RECQL P46063 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CA2 P00918 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10407445 0.83 RAPGEF4 (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19POLB
SCHEMBL5342294 0.80 ALDH1A1 (0.42) ALDH1A1CYP3A4CYP2C9CYP2C19POLB
SCHEMBL28023659 0.77 PLCG1 (0.60) POLBKMT2AMAPTRECQLCA2
SCHEMBL7405609 0.75 TP53 (0.42) ALDH1A1CYP3A4CYP2C9CYP2C19HPGD
SCHEMBL11686796 0.74 GAA (0.41) ALDH1A1POLBKDM4EGAAMEN1
SCHEMBL11137010 0.73 MCHR1 (0.45) ALDH1A1CYP3A4CYP2C9CYP2C19POLB
SCHEMBL11060404 0.73 MCHR1 (0.45) ALDH1A1CYP3A4CYP2C9CYP2C19POLB
SCHEMBL22057011 0.73 GLA (0.36) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11529208 0.72 CA2 (0.50) ALDH1A1CYP3A4POLBKDM4EMEN1
SCHEMBL15478494 0.72 L3MBTL1 (0.44) ALDH1A1MEN1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139522-A2 MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS Colby Pharmaceutical Company (US) 2010-01-06 — — EP disclosed
WO-2008109740-A2 MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS COLBY PHARMACEUTICAL COMPANY (US) 2008-09-12 — — WO disclosed
Send feedback